1 / 48

Electrolyte balance

Electrolyte balance. Ji-Eun Lee. Division of Nephrology, Department of Internal Medicine, Wonkwang Univ. Sanbon Hospital. 만성 신부전 환자에게서 발생하는 전해질 이상은 ? 칼륨대사 칼슘대사 인대사 신장골형성장애. Symptoms of ESRD. Dysregulation of ECF volume Dysregulation of plasma osmolality Electrolyte dysregulation

gore
Télécharger la présentation

Electrolyte balance

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Electrolyte balance Ji-Eun Lee Division of Nephrology, Department of Internal Medicine, Wonkwang Univ. Sanbon Hospital

  2. 만성 신부전 환자에게서 발생하는 전해질 이상은? • 칼륨대사 • 칼슘대사 • 인대사 • 신장골형성장애

  3. Symptoms of ESRD • Dysregulation of ECF volume • Dysregulation of plasma osmolality • Electrolyte dysregulation • Calcitriol deficiency • Erythropoietin deficiency • Uremia

  4. Non-exchange bone Na 1300 mEq Exchange bone Na Dense connective tissue, cartilage 1000 mEq Na intake 100 mEq/day Extracellular Na 1700 mEq Net: 96 mEq/day intestine Intracellular Na 100 mEq kidney Feces 4 mEq/day Renal Na excretion 96 mEq/day

  5. Brain adaptation to dysnatremia

  6. Symptom of hypernatremia • Mortality: 40-70%(8-40%) • Alteration in brain water content • Clincal manifestation : rapidity of onset, duration, magnitude • ICH, subarachnoid hemorrhage • Nausea, muscle weakness, fasciculation, alteration in mental status(lethargy-coma)

  7. Flow of water & sodium

  8. Symptom of hyponatremia • Alteration in brain water content • Brain edema: neurologic symptoms • Sx : degree & severity(125mEq) of hypoosmolality

  9. Intracellular K 3500 mEq K intake 100 mEq/day Extracellular K 50 mEq Net: 92 mEq/day intestine kidney Feces 8 mEq/day Renal K excretion 92 mEq/day

  10. Potassium Flow between Glomerular Filtrate & Urine

  11. Regulation of Potassium secretion & excretion • Aldosterone • Plasma potassium concentration • Tubular flow rate • Antidiuretic hormone

  12. Clinical Manifestaions of Hypokalemia • EKG abnormality • Ventricular arrhythmia • Skeletal muscle weakness, paralysis : lower ext, respiratory arrest • Decreased motility of smooth muscle : ileus, urinary retention • Rhabdomyolysis • Nephrogenic diabetes insipidus

  13. Clinical Manifestaions of Hypokalemia • EKG abnormality • Skeletal muscle weakness • Impair urinary acidification: RTA • Stimulate endogenous aldosterone

  14. EKG changes in dyskalemia

  15. Potassium Contents

  16. Hypokalemia • Decrease intake • Increased loss : TTKG (transtubular K gradient) = Uk/Pk÷ Uosm/Posm Renal – aldostererone excess, drugs, renal tubular defects … GI – vomiting, NG suction, diarrhea … • Transcellular shifts : alkalosis, insulin, β2-agonists, * Hypokalemic periodic paralysis

  17. Neuromuscular : lethargy, depression, irritability, confusion paresthesia, depressed DTR, fasciculations, myalgia, prominent muscle weakness, muscular paralysis rhabdomyolysis • Cardiovascular : palpitation, postural hypotension, ectopy, dysrhythmia first- & second-degree heart block, AF, PVC, VF, asystole *ECG – flattening of T wave, ST segment depression, U wave • GI : N/V, abdominal distention, paralytic ileus • Renal : polyuria, polydipsia, impaired ability to concentrate urine or excrete an acid load

  18. Management of hypokalemia • Prevention of further K+ loss • Oral KCl : K-contin 1T = 600mg = 8.05mEq initial dose 60-80mEq/day • Solution : Non-dextrose (N/S or ½ N/S) • Route : peripheral 40-60mEq/L central 60-200mEq/L(femoral) • Infusion rate : 10-20mEq/hr 40mEq/hr (K<1.5 or arrhythmia)

  19. Hyperkalemia • Pseudohyperkalemia : hemolysis, leukocytosis, thrombocytosis • ↑ K intake and absorption : transfusion, dietary, K supplements • Impaired renal excretion : renal failure, tubular defects, ↓aldosterone (TTKG <6) • Transcellular shifts : acidosis, insulin deficiency, β-blocker, digitalis toxicity, succinylcholine, exercise, HPP • Cellular injury : rhabdomyolysis, severe intravascular hemolysis, tumor lysis synd., burn and crush injury

  20. Cardiovascular : dysrhythmia, second- and third degree heart block, wide-complex tachycardia, VF, asystole, * ECG : peaked T wave, loss of P wave, widening and slurring of QRS complex, sine wave • Neuromuscular : muscle cramps, weakness, paralysis, paresthesia, tetany, focal neurologic deficit

  21. Management of hyperkalemia • Calcium gluconate : Calcose 0.5-1@/IV over 2-3min EKG 변화 없으면 5-10분후 repeat • GI coctail : 10% D/W 1L + Bivon 4@ + RI 20U 150gtt for 30min(300ml), 60gtt for 3hrs(700ml) • Ventolin nebulizer • Oral kalliminate : 30g/#3 (25-50g + 100ml of 20% sorbitol) • Kalliminate enema : kalliminate 50g + 20% D/W 200ml 30min retention • Lasix 40-160mg/IV • Hemodialysis

  22. Bone Ca 1300 g Ca intake 700 mg/day Net: 200 mg/day Extracellular Ca 2 g intestine Intracellular Ca 5 g kidney Feces 500 mg/day Renal Ca excretion 200 mg/day

  23. Bone Phsophorus 520 g P intake 1200 mg/day Net: 800 mg/day Extracellular P 0.5 g intestine Intracellular P 80 g kidney Feces 400 mg/day Renal P excretion 800 mg/day

  24. PTH • : bone Ca resorption • : renal Ca absorption • : renal phosphate excretion • : Vit-D(active metabolite) •  intestinal Ca absorption • Vitamin D • : intestinal Ca, P absorption • : inhibit PTH on bone • : renal Ca absorption(minor)

  25. Ca vs. PTH

  26. Homeostatic mechanism for P balance Plasma PO4 renal P absorption Intestinal P absorption Calcitriol Intestinal Ca absorption Plasma Ca Bone resorption of Ca PTH

  27. Vit-D3 metabolism 7-Dehydrocholesterol Skin UV light diet Cholecalciferol (vitamine D3) liver 25-hydroxycholecalciferol kidney 1α-hydroxylase Calcitriol

  28. Causes of HyperCa • increased Ca absorption from GI tract • hypercalcemia in renal failure • increased resorption of Ca from bone : 1’ hyperparathyroidism : 2’ hyperparathyroidism : maligancy : hyperthyroidism

  29. Sx & Signs of HyperCa • Sx: severity & rapidity of the rise of iCa • Mild: generally asymptomatic • Severe: neurologic(mental change to coma) GI symptom(constipation, anorexia, nausea)

  30. Causes of HypoCa • Hypoparathyroidism: hypoMg • Defect in vit D metabolism : nutritional, malabsorption, liver dz, kidney dz

  31. Sx & Signs of HypoCa • Threshold of Sx : serum pH, hypoMg, hypoK, hypo Na • Neuromuscular excitability : circumoral & distal extremity paresthesia : carpopedal spasm

  32. HyperP • Causes : Renal failure : Sudden, massive P load : Primary increases in tubular P reabsorption • Sx & signs • : result of comcomitant hypocalcemia

  33. HypoP • Causes : redistribution of EC P into IC space : decrease in intestinal absorption of P : decrease in renal reabsorption of P • Sx & signs : diaphragmatic function : leftward shift in oxygen dissociation curve : reversible myocardial function

  34. Renal Osteodystrophy

  35. Bone • Organic component(35%) : Cell matrix: collagen fiber(90%) ground substance (proteoglycan, ECF)) osteoblast • Bone salts(65%) : Ca, P(hydroxyapatite),Mg, Na, K

  36. Skeletal abnormality in ROD

  37. Classification of ROD Feature Increased osteoid surfance Marrow fibrosis Low bone formation Increased unmineralized osteoid Marrow fibrosis and increased Unmineralized osteoid Disorder Normal/high turn over mild osteitis fibrosa Low turn over aplastic(adynamic) osteomalacia Mixed uremic OD

  38. Phosphate retention & 2’ hyperparathyroidism

  39. Symptoms • Musculoskeletal Sx : bone pain- lower back, hips. Legs muscle weakness bone deformity • Pururitus • Metastatic calcification

  40. Treatment of ROD

More Related